Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/04/2007US20070231301 Parenteral low dose type 1 interferons for bladder cancer
10/04/2007US20070231299 Immunostimulant; antibodies used to measure efficacy; dendritic and antigen presenting cells; lung and renal cancer
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007US20070231264 Mammalian cytokine; related reagents
10/04/2007US20070231261 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers
10/04/2007DE102006015341A1 Behandlung von multipler Sklerose und/oder rheumatoider Arthritis Treatment of multiple sclerosis and / or rheumatoid arthritis
10/04/2007CA2647449A1 Binding member for gm-csf receptor
10/04/2007CA2647287A1 Mycobacterium tuberculosis complex with inactivated phop and without dim production for tuberculosis vaccine
10/04/2007CA2647268A1 Methods for treating kidney disorders
10/04/2007CA2647111A1 Anti-igf-1r human monoclonal antibody formulation
10/04/2007CA2646993A1 Regimens for immunisation with meningococcal conjugates
10/04/2007CA2646349A1 Storage of influenza vaccines without refrigeration
10/04/2007CA2645496A1 Gdf-9/bmp-15 modulators for the treatment of bone disorders
10/04/2007CA2635599A1 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases
10/04/2007CA2633142A1 Chlamydial antigens
10/04/2007CA2632215A1 Il-21 monoclonal antibodies
10/04/2007CA2604334A1 Toll-like receptor 4 (tlr4)-neutralizing humanized antibodies
10/03/2007EP1840214A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
10/03/2007EP1840209A2 Adeno-associated virus vectors and use thereof
10/03/2007EP1840135A1 Anti-alhpha 9 integrin antibody and the use thereof
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839673A2 Prevention and treatment of hypergastrinemia
10/03/2007EP1839672A2 Modified vaccinia virus Ankara for the vaccination of neonates
10/03/2007EP1838863A1 Methods for the production of ansamitocins
10/03/2007EP1838854A2 Humanized antibodies that recognize beta amyloid peptide
10/03/2007EP1838737A2 Binding proteins specific for human matriptase
10/03/2007EP1838736A2 Cripto binding molecules
10/03/2007EP1838734A2 Antibodies against antigen presenting cells and uses thereof
10/03/2007EP1838732A2 Biomarkers for melanoma
10/03/2007EP1838731A1 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations
10/03/2007EP1838729A2 Tumor antigens for use in diagnosis and therapy
10/03/2007EP1838349A1 Amyloid beta antibodies for use in improving cognition
10/03/2007EP1838348A1 Humanized amyloid beta antibodies for use in improving cognition
10/03/2007EP1838347A1 Pharmaceutical compositions for treating diseases associated with nf-kappab activity
10/03/2007EP1838346A2 Method of producing conjugate vaccines
10/03/2007EP1838345A2 Saccharide conjugate vaccines
10/03/2007EP1838344A1 Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
10/03/2007EP1838343A2 Improved prrs vaccines
10/03/2007EP1838342A2 Methods to bypass cd+4 cells in the induction of an immune response
10/03/2007EP1838341A1 Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide
10/03/2007EP1838340A1 Flagellin related polypeptides and uses thereof
10/03/2007EP1838339A2 Ager-peptides and use thereof
10/03/2007EP1838338A2 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
10/03/2007EP1838328A2 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
10/03/2007EP1838326A1 Process for producing polypeptide mixtures using hydrogenolysis
10/03/2007EP1543113B1 Chicken astrovirus type 2
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1351744B1 Use of specific erbb4 antagonists for treating stenosis
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1267839B1 Microspheres for active embolization
10/03/2007EP1227840B1 Adjuvanted genetic vaccines
10/03/2007EP1187916B1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
10/03/2007EP1135482B1 Cancer cell vaccine
10/03/2007EP1100942B1 Herpes virus vectors for dendritic cells
10/03/2007EP1044013B9 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
10/03/2007EP1037974B1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
10/03/2007EP0563093B2 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/03/2007CN101048659A Monoclonal antibodies to progastrin
10/03/2007CN101048502A Modified human hepatitis c virus genomic rna having autonomous replicative competence
10/03/2007CN101048498A Virosome particles comprising antigens from influenza virus and hepatitis b virus
10/03/2007CN101048497A Method for acquiring and applying needed raw material for reccogniting self antigen immunity
10/03/2007CN101048425A KID3 and KID3 antibodies that bind thereto
10/03/2007CN101048424A Methods of using death receptor ligands and CD20 antibodies
10/03/2007CN101048178A Combination of a recombinant mycobacterium and a biologically active agent as a vaccine
10/03/2007CN101048177A Multivalent meningococcal derivatized polysaccharide-proteinconjugates and vaccine
10/03/2007CN101048176A Liquid allergy vaccine formulation for oromucosal administration
10/03/2007CN101048175A Immunogenic bacterial vesicles with outer membrane proteins
10/03/2007CN101048174A Composition comprising vlp and amyloid-beta peptide
10/03/2007CN101048172A Hcv vaccines for chronic hcv patients
10/03/2007CN101045924A Prepn and application of recombinant staphylococcus aureus enterotoxin O
10/03/2007CN101045917A Swine reproduction and respiration syndrome vaccine and its prepn process and application
10/03/2007CN101045751A Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof
10/03/2007CN101045164A Double-chain structured polyethylene active derivatives, and ligature with other molecules
10/03/2007CN101045161A Modulators of P-selectin glycoprotein ligand 1
10/03/2007CN101045160A Hydrophobic agent used for target treatment to tumor blood vessel, its preparing method and use
10/03/2007CN101045159A Method for preparing vaccine to chicken coccidiosis
10/03/2007CN101044884A Method for prepairng feed additives containing yolk anti body
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340294C Remedy for spinal injury containing interleukin-6 antagonist
10/03/2007CN100340291C F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy
10/03/2007CN100340289C Method to enhance an immune response of nucleic acid vaccination
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276589 Using immunoaffinity matrix to isolate immunoglobulin angiogenesis inhibitors for use in treatment of vision, inflammatory and cell proliferative disorders
10/02/2007US7276588 Antibody of human mitochondrial voltage dependent anion channel
10/02/2007US7276585 Immunoglobulin variants outside the Fc region
10/02/2007US7276581 Tyrosine kinases; phosphoproteins; antibodies; transgenic mice whose somatic or germ cells express tumors
10/02/2007US7276579 Immunogenic proteoliposomes, and uses thereof
10/02/2007US7276489 At least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a nonnucleotidic linker, at least one oligonucleotide an immunostimulant having accessible 5' end
10/02/2007US7276483 Polypeptide which interfers with amyloid formation
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276473 Combination of pancreatic cell surface marker binding agent, polypeptide translocation transfer element and enzymatic secretion inhibitor
10/02/2007US7276372 Antibodies against GPR64 and uses thereof
10/02/2007US7276371 Stimulation of hematopoietic cells in vitro
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
10/02/2007US7276350 Method for diagnosing infectious diseases
10/02/2007US7276341 Methods and reagents for diagnosis of autoantibodies
10/02/2007US7276333 Viral infection inhibitor targeting integrase N-terminal domain
1 ... 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 ... 1823